Tagged with Healthcare,

Greece John Kandylis, GM of Greek logistics market leader Olympias, discusses his company’s unique service offering, negotiating the issues brought about by the financial crisis, and retaining a family-run spirit while expanding internationally. Olympias SA is positioned as a market leader in logistics with deep expertise in the field. Could you…

Mexico President and CEO of Grupo ENESA, Jaime Chico Pardo breaks down the private capital fund’s core investment pillars—centered on active management and driving long-term value—while elaborating on the flourishing opportunities where technology and healthcare intersect, and how this marriage serves to close Mexico’s encroaching healthcare gaps. Jaime, can you start…

Mexico Roberto Tapia-Conyer, General Director at the Carlos Slim Foundation, explains the unique position of the Foundation to develop and introduce innovation that could create breakthroughs in the National Healthcare System as well as enhance patients’ quality of life. Could you please give our international audience an update on the operations…

Europe Europe accounts for 22.2 percent of global pharma sales; more than Africa, Asia, Australasia, and Latin America combined, but less than half of North America. The biopharmaceutical industry is a key contributor to the European economy in terms of both trade surplus and employment; especially highly-skilled R&D jobs. Germany is…

Mexico Representatives of Olivares, one of the leading law firms in Mexico, explain the evolving status of cannabis and narcotics for medicinal use in the country. A new Bill authorizing the use of cannabis for medical treatments was passed by the Senate in December 2016, but there is still a long…

Asia 2016 was a year of great activity for the pharma industry, with economic uncertainties, seismic political shifts in the UK and US, and cost-containment measures in several countries. Consequently, PharmaBoardroom surveyed over 400 of its executive readership over four continents to get a sense of their optimism for the industry in 2017.…

Singapore Callum Bir explains Microsoft’s vision and strategy for leveraging the transformative power of technology in healthcare, particularly in terms of its world-leading capabilities in Artificial Intelligence. While Microsoft is ubiquitous, our readers may not be familiar with your role in the healthcare sector. To begin, could you give us an overview…

Greece Outspoken, charismatic and dedicated General Manager of Pierre-Fabre Greece, Philippe Lambrinos, shares his insights on the company’s presence and performance in the challenging Greek market, how it’s manoeuvring issues of market access and clawbacks, as well as his overarching vision for Pierre-Fabre in Greece. Mr. Lambrinos, you have spent 21…

Greece As the trusted source of premier market intelligence, IMS stands as a formidable force that many companies rely on for guidance through the unpredictable Greek pharmaceutical landscape. General Manager Nikolaos Kostaras proudly speaks about spearheading the affiliate through many transformative changes, defining its core proficiencies and looking to the future…

Mexico Abelardo Meneses García, General Director at the National Cancer Institute of Mexico (INCan), explains the evolution of cancer’s footprint in Mexico and showcases how the institute has been investing in enlarging its capabilities to become the national and regional reference for cancer treatment. Could you please introduce to our international…

Healthcare PharmaBoardroom has spoken to a wide variety of actors at the cutting edge of healthcare digitalization over the past 12 months. Hot topics have included the healthcare industry’s slow reaction to digital trends, new modes of hospital care, homecare, and digitalization’s potential to expand access in remote and underdeveloped areas.…

Ireland Brendan McAtamney, CEO of UDG Healthcare, details the company’s impressive growth in recent years, particularly in North America, across both their Sharp and Ashfield business units. He also expands on the company’s proactive M&A strategy as well as his vision for UDG Healthcare in the coming years. You were appointed…